Assembly Biosciences Inc
ASMB
Get informed when a big investor buys or sells
+ FollowMarket Cap$424.02M
Close$
$0.18
99.4% downside
Current Fair Value
99.4% downsideOvervalued by 99.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $424.02 Million |
|---|---|
| Enterprise Value | $410.39 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.55 |
| Beta | 1.08 |
| Outstanding Shares | 16,900,232 |
Return
| Return on Equity | -0.01% |
|---|---|
| Return on Assets | -0.01% |
| Return on Invested Capital | -2.92% |
Valuation & Multiples
| P/E Ratio | -46 |
|---|---|
| PEG | 73.98 |
| Price to Sales | 14.98 |
| Price to Book Ratio | 1.66 |
| Enterprise Value to Revenue | 9.54 |
| Enterprise Value to EBIT | -45.8 |
| Enterprise Value to Net Income | -9772 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.72
Average shareholder expectationRevenue Estimate
$8.60 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 80.29%▼ 42.13% |
|---|---|
| Total Invested | $376.38M▼ 19.35% |
| Investors Holding | 74▲ 5.00% |
ESG Score
No data